Equillium Statistics
Total Valuation
Equillium has a market cap or net worth of $16.79 million. The enterprise value is -$5.40 million.
Important Dates
The next estimated earnings date is Thursday, May 8, 2025, after market close.
Earnings Date | May 8, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Equillium has 35.72 million shares outstanding. The number of shares has increased by 1.82% in one year.
Current Share Class | 35.72M |
Shares Outstanding | 35.72M |
Shares Change (YoY) | +1.82% |
Shares Change (QoQ) | +0.09% |
Owned by Insiders (%) | 19.60% |
Owned by Institutions (%) | 6.86% |
Float | 18.29M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.40 |
Forward PS | n/a |
PB Ratio | 0.88 |
P/TBV Ratio | 0.88 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.93, with a Debt / Equity ratio of 0.02.
Current Ratio | 3.93 |
Quick Ratio | 3.73 |
Debt / Equity | 0.02 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -38.75% and return on invested capital (ROIC) is -24.13%.
Return on Equity (ROE) | -38.75% |
Return on Assets (ROA) | -13.58% |
Return on Invested Capital (ROIC) | -24.13% |
Return on Capital Employed (ROCE) | -42.96% |
Revenue Per Employee | $1.17M |
Profits Per Employee | -$230,486 |
Employee Count | 35 |
Asset Turnover | 1.08 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, Equillium has paid $361,000 in taxes.
Income Tax | 361,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -74.39% in the last 52 weeks. The beta is 1.86, so Equillium's price volatility has been higher than the market average.
Beta (5Y) | 1.86 |
52-Week Price Change | -74.39% |
50-Day Moving Average | 0.67 |
200-Day Moving Average | 0.78 |
Relative Strength Index (RSI) | 40.25 |
Average Volume (20 Days) | 184,454 |
Short Selling Information
The latest short interest is 283,162, so 0.79% of the outstanding shares have been sold short.
Short Interest | 283,162 |
Short Previous Month | 363,002 |
Short % of Shares Out | 0.79% |
Short % of Float | 1.55% |
Short Ratio (days to cover) | 2.08 |
Income Statement
In the last 12 months, Equillium had revenue of $41.10 million and -$8.07 million in losses. Loss per share was -$0.23.
Revenue | 41.10M |
Gross Profit | 41.10M |
Operating Income | -8.27M |
Pretax Income | -7.81M |
Net Income | -8.07M |
EBITDA | -8.13M |
EBIT | -8.27M |
Loss Per Share | -$0.23 |
Full Income Statement Balance Sheet
The company has $22.58 million in cash and $384,000 in debt, giving a net cash position of $22.19 million or $0.62 per share.
Cash & Cash Equivalents | 22.58M |
Total Debt | 384,000 |
Net Cash | 22.19M |
Net Cash Per Share | $0.62 |
Equity (Book Value) | 19.06M |
Book Value Per Share | 0.54 |
Working Capital | 18.62M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$19.03 million and capital expenditures -$85,000, giving a free cash flow of -$19.11 million.
Operating Cash Flow | -19.03M |
Capital Expenditures | -85,000 |
Free Cash Flow | -19.11M |
FCF Per Share | -$0.54 |
Full Cash Flow Statement Margins
Gross margin is 100.00%, with operating and profit margins of -20.12% and -19.63%.
Gross Margin | 100.00% |
Operating Margin | -20.12% |
Pretax Margin | -18.75% |
Profit Margin | -19.63% |
EBITDA Margin | -19.79% |
EBIT Margin | -20.12% |
FCF Margin | n/a |
Dividends & Yields
Equillium does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -1.82% |
Shareholder Yield | -1.82% |
Earnings Yield | -48.05% |
FCF Yield | -113.84% |
Analyst Forecast
The average price target for Equillium is $3.00, which is 538.30% higher than the current price. The consensus rating is "Buy".
Price Target | $3.00 |
Price Target Difference | 538.30% |
Analyst Consensus | Buy |
Analyst Count | 3 |
Revenue Growth Forecast (5Y) | 17.47% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Equillium has an Altman Z-Score of -5.31 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -5.31 |
Piotroski F-Score | 2 |